Emphascience, Inc.

Unique technical skill-set to optimize and differentiate approved medicines to increase value and market in fraction of the time and cost required for new drugs

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Pittsford, NY, US
  • Currency USD
  • Founded October 2010
  • Employees 5
  • Incorporation Type C-corp
  • Website emphascience.com

Company Summary

Innovative pharmaceutical company with extraordinary scientific skills to improve efficacy, safety, and convenience of marketed products. We overcome stiff technical and patent obstacles to design novel patentable formulations and out-license them against milestones and royalty. Our portfolio targets >$5 billion of approved product market; requires no clinical POC studies; costs <$2-5million per product; and can be in market in 2-5 years.

Team

  • Rebanta Bandyopadhyay
    Founding Principal, Member of the Board, and President & CEO

    Over 18 years in pharmaceutical product design at the interface of drug discovery and development; leadership and team-building; raising capital for new ventures.

  • Susen Bandyopadhyay
    Founding Principal, Member of the Board, and Chief Operating Officer

    Synthetic organic and medicinal chemistry. Understanding of reaction chemistry as it applies to drug stability in solution. Sourcing and administration.

Advisors

  • Raman Kapur
    Unconfirmed

Previous Investors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free